135 related articles for article (PubMed ID: 28349651)
1. Dermasence refining gel modulates pathogenetic factors of rosacea in vitro.
Borelli C; Becker B; Thude S; Fehrenbacher B; Isermann D
J Cosmet Dermatol; 2017 Dec; 16(4):e31-e36. PubMed ID: 28349651
[TBL] [Abstract][Full Text] [Related]
2. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.
Coda AB; Hata T; Miller J; Audish D; Kotol P; Two A; Shafiq F; Yamasaki K; Harper JC; Del Rosso JQ; Gallo RL
J Am Acad Dermatol; 2013 Oct; 69(4):570-7. PubMed ID: 23871720
[TBL] [Abstract][Full Text] [Related]
3. Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin.
Lee JB; Bae SH; Moon KR; Na EY; Yun SJ; Lee SC
Exp Dermatol; 2016 Dec; 25(12):956-961. PubMed ID: 27315464
[TBL] [Abstract][Full Text] [Related]
4. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
Front Immunol; 2021; 12():609615. PubMed ID: 34322115
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of IL-33 in rosacea skin and UVB-irradiated and LL-37-treated HaCaT cells.
Suhng E; Kim BH; Choi YW; Choi HY; Cho H; Byun JY
Exp Dermatol; 2018 Sep; 27(9):1023-1029. PubMed ID: 29873850
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.
Kim JY; Kim YJ; Lim BJ; Sohn HJ; Shin D; Oh SH
Yonsei Med J; 2014 Nov; 55(6):1648-55. PubMed ID: 25323904
[TBL] [Abstract][Full Text] [Related]
7.
Roh KB; Ryu DH; Cho E; Weon JB; Park D; Kweon DH; Jung E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256158
[TBL] [Abstract][Full Text] [Related]
8. Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea.
Zhang J; Xu X; Rao NV; Argyle B; McCoard L; Rusho WJ; Kennedy TP; Prestwich GD; Krueger G
PLoS One; 2011 Feb; 6(2):e16658. PubMed ID: 21347371
[TBL] [Abstract][Full Text] [Related]
9. Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.
Thibaut de Ménonville S; Rosignoli C; Soares E; Roquet M; Bertino B; Chappuis JP; Defoin-Platel/Chaussade C; Piwnica D
Dermatol Ther (Heidelb); 2017 Jun; 7(2):213-225. PubMed ID: 28243927
[TBL] [Abstract][Full Text] [Related]
10. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes.
Yamasaki K; Kanada K; Macleod DT; Borkowski AW; Morizane S; Nakatsuji T; Cogen AL; Gallo RL
J Invest Dermatol; 2011 Mar; 131(3):688-97. PubMed ID: 21107351
[TBL] [Abstract][Full Text] [Related]
11. Epidermal proteases in the pathogenesis of rosacea.
Meyer-Hoffert U; Schröder JM
J Investig Dermatol Symp Proc; 2011 Dec; 15(1):16-23. PubMed ID: 22076323
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel.
Kim M; Kim J; Jeong SW; Jo H; Woo YR; Park HJ
Exp Dermatol; 2017 Nov; 26(11):1143-1145. PubMed ID: 28500634
[TBL] [Abstract][Full Text] [Related]
13. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea.
Salzer S; Kresse S; Hirai Y; Koglin S; Reinholz M; Ruzicka T; Schauber J
J Dermatol Sci; 2014 Dec; 76(3):173-9. PubMed ID: 25306296
[TBL] [Abstract][Full Text] [Related]
14. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.
Yamasaki K; Di Nardo A; Bardan A; Murakami M; Ohtake T; Coda A; Dorschner RA; Bonnart C; Descargues P; Hovnanian A; Morhenn VB; Gallo RL
Nat Med; 2007 Aug; 13(8):975-80. PubMed ID: 17676051
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency irradiation attenuates angiogenesis and inflammation in UVB-induced rosacea in mouse skin.
Son M; Park J; Oh S; Choi J; Shim M; Kang D; Byun K
Exp Dermatol; 2020 Jul; 29(7):659-666. PubMed ID: 32434270
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.
Chen M; Xie H; Chen Z; Xu S; Wang B; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Li J; Deng Z
Biomed Pharmacother; 2019 Aug; 116():109011. PubMed ID: 31132668
[TBL] [Abstract][Full Text] [Related]
17. Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.
Zhu Y; Underwood J; Macmillan D; Shariff L; O'Shaughnessy R; Harper JI; Pickard C; Friedmann PS; Healy E; Di WL
J Allergy Clin Immunol; 2017 Nov; 140(5):1310-1322.e5. PubMed ID: 28238749
[TBL] [Abstract][Full Text] [Related]
18. Mast cell stabilization: new mechanism underlying the therapeutic effect of intense pulsed light on rosacea.
Jiang P; Liu Y; Zhang J; Liu Y; Li M; Tao M; Zhang Y; Tang Z; Liu W; Xu Y
Inflamm Res; 2023 Jan; 72(1):75-88. PubMed ID: 36329130
[TBL] [Abstract][Full Text] [Related]
19. Elevated Tear Human Neutrophil Peptides 1-3, Human Beta Defensin-2 Levels and Conjunctival Cathelicidin LL-37 Gene Expression in Ocular Rosacea.
Gökçınar NB; Karabulut AA; Onaran Z; Yumuşak E; Budak Yıldıran FA
Ocul Immunol Inflamm; 2019; 27(7):1174-1183. PubMed ID: 30142005
[No Abstract] [Full Text] [Related]
20. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid.
Morizane S; Yamasaki K; Kabigting FD; Gallo RL
J Invest Dermatol; 2010 May; 130(5):1297-306. PubMed ID: 20090765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
